Delaware SB 21: Status and Risk Management Implications for Directors and Officers
Delaware’s Senate Bill 21 (SB 21), signed into law by Governor Matt Meyer on March 25, 2025, amends the Delaware General Corporation Law (DGCL) and took effect immediately. The law addresses concerns about “DExit”—a term for companies potentially leaving Delaware for states like Nevada or Texas due to litigation risks or perceived judicial overreach. This article outlines what SB 21 means for directors and officers.
Key Changes in SB 21
SB 21 modifies DGCL Sections 144 (conflicted transactions) and 220 (shareholder record demands). For conflicted transactions where directors, officers, or controlling stockholders have a personal interest affecting their independence or objectivity, directors and officers gain stronger protection. If directors and officers are involved in a deal where they have a personal interest, they are shielded from lawsuits or equitable challenges if the transaction is approved in good faith, without gross negligence, by a fully informed majority of disinterested directors (or a committee of at least two independent directors) or by a majority of disinterested shareholders. The deal may be protected if it is fair to the corporation. This allows directors and officers to rely on the business judgment rule, avoiding the stricter “entire fairness” standard.
Controlling stockholders—those with at least one-third voting power and managerial authority—also get safe harbor protections for transactions (except “going private” deals) if approved by an independent board committee or disinterested shareholders. “Going private” transactions require both. If these conditions are not met, the “entire fairness” standard applies. Directors of public companies are presumed independent unless evidence indicates a significant conflict. Controlling shareholders are exempt from duty of care claims without needing charter provisions.
For shareholder record demands, SB 21 limits access to formal documents like bylaws or financial statements unless a “compelling need” for additional records, like emails, is proven with “clear and convincing evidence.” Shareholders must show a “proper purpose” and request records from the past three years. Companies can impose confidentiality restrictions and redact unrelated information, reducing the risk of litigation based on these demands.
Risk Management Implications for Directors and Officers
SB 21 reduces litigation exposure for directors and officers by strengthening protections in conflicted transactions and shareholder demands, but it requires careful risk management to fully leverage these benefits. The expanded safe harbors under Section 144 allow directors and officers to pursue complex transactions with greater confidence, as clear approval processes—such as good-faith, fully informed decisions by disinterested directors or shareholders—invoke the business judgment rule, shielding against fiduciary duty lawsuits. The presumption of independence for public company directors further complicates plaintiffs’ challenges to board decisions. For directors and officers collaborating with controlling stockholders, the safe harbor protections streamline transactions, provided they act in good faith and disclose material facts.
The tightened Section 220 rules curb shareholder access to informal records, decreasing the likelihood of costly investigations or derivative lawsuits alleging mismanagement. To mitigate remaining risks, directors and officers should prioritize robust documentation of approvals, clear disclosures, and enhanced compliance programs to ensure decisions withstand judicial scrutiny for good faith and absence of gross negligence.
However, the perception of reduced accountability may invite reputational risks, particularly with activist investors or institutional shareholders, necessitating proactive stakeholder communication. SB 21’s retroactive application (except for pending cases or pre-February 17, 2025, demands) may protect past actions, but untested provisions could spark legal challenges, creating uncertainty. Directors and officers should consult legal counsel regularly, update D&O insurance to address potential gaps, and align risk management strategies with the evolving judicial landscape to navigate these changes effectively.
Context and Outlook
SB 21 was fast-tracked to keep Delaware competitive as a corporate hub, especially after cases like the Tesla compensation dispute fueling DExit concerns. Delaware’s corporate franchise generates about $2.2 billion annually, and the law aims to prevent companies from reincorporating elsewhere. Supporters argue it balances corporate and shareholder interests, but critics, including investors and scholars, say it favors insiders and weakens minority shareholder rights, dubbing it the “Billionaires’ Bill.”
Courts may see challenges as they interpret the new rules, particularly around safe harbor requirements or director independence. The law applies retroactively, except for pending cases or record demands before February 17, 2025, which could impact ongoing disputes but also prompt legal pushback. Directors and officers should consult corporate counsel to navigate these changes and monitor judicial developments.
Conclusion
SB 21 strengthens protections for directors and officers, offering clearer rules and reduced litigation risks in conflicted transactions and shareholder demands. While it bolsters Delaware’s corporate appeal, potential legal challenges and investor concerns linger. Directors and officers should stay informed and seek legal guidance to leverage these changes effectively.